Speaker illustration

Doctor Germaine Loo

National Heart Centre Singapore, Singapore (Singapore)

Member of:

European Society of Cardiology

Real-world outcomes of Selexipag for treatment of pulmonary hypertension in an Asian population

Event: ESC Asia 2022 with APSC & AFC

Topic: Treatment

Session: Poster Session 3


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb